H_TNFRSF25(DR3) CHO-K1 Cell Line
Cat. No.
GM-C28600
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C28600
Product H_TNFRSF25(DR3) CHO-K1 Cell Line
Description H_TNFRSF25(DR3) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human TNFRSF25(DR3).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TNFRSF25(DR3)
Gene ID/Uniprot ID Q93038-1(AA Met 1 - Gln 199)
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C28600
Product H_TNFRSF25(DR3) CHO-K1 Cell Line
Description H_TNFRSF25(DR3) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human TNFRSF25(DR3).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TNFRSF25(DR3)
Gene ID/Uniprot ID Q93038-1(AA Met 1 - Gln 199)
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_TNFRSF25(DR3) CHO-K1 Cell Line (Cat. GM-C28600) was determined by flow cytometry using Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) (Cat. GM-58913AB).
Stability
The passage stability of the H_TNFRSF25(DR3) CHO-K1 Cell Line (Cat. GM-C28600) was determined by flow cytometry using Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) (Cat. GM-58913AB).
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) Genomeditech/GM-58913AB
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) Genomeditech/GM-58913AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Sequence

  TNFRSF25(DR3) Q93038-1(SP-ECD):MEQRPRGCAAVAAALLLVLLGARAQGGTRSPRCDCAGDFHKKIGLFCCRGCPAGHYLKAPCTEPCGNSTCLVCPQDTFLAWENHHNSECARCQACDEQASQVALENCSAVADTRCGCKPGWFVECQVSQCVSSSPFYCQPCLDCGALHRHTRLLCSRRDTDCGTCLPGFYEHGDGCVSCPTSTLGSCPERCAAVCGWRQ

  TNFRSF25(DR3) Q93038-1(SP-ECD):MEQRPRGCAAVAAALLLVLLGARAQGGTRSPRCDCAGDFHKKIGLFCCRGCPAGHYLKAPCTEPCGNSTCLVCPQDTFLAWENHHNSECARCQACDEQASQVALENCSAVADTRCGCKPGWFVECQVSQCVSSSPFYCQPCLDCGALHRHTRLLCSRRDTDCGTCLPGFYEHGDGCVSCPTSTLGSCPERCAAVCGWRQ

Related products
IL-23
H_IL-23 Reporter 293 Cell Line H_IL-23 Reporter 293 DDX35TM Cell Line Cynomolgus_IL-23R HEK-293 Cell Line
H_IL-23R HEK-293 Cell Line H_IL-23R IL12RB1 HEK-293 Cell Line Membrane bound H_IL-23 CHO-K1 Cell Line
Anti-IL23A hIgG1 Reference Antibody (Gusebio) Anti-IL23A hIgG1 Reference Antibody (Risbio) Anti-IL-23R hIgG1 Antibody(5D4)
Biotinylated Human IL-23A&IL-12B Heterodimer Protein; His-Avi Tag Cynomolgus IL-23A & Human IL-12B Heterodimer Protein; His Tag Cynomolgus IL-23A & Mouse IL-12B Heterodimer Protein; His Tag
Cynomolgus IL-23R Protein; hFc Tag Human IL-23A & Mouse IL-12B Heterodimer Protein; His Tag Human IL-23A&IL-12B Heterodimer Protein; His Tag
Human IL-23R Protein; hFc Tag Human IL-23R Protein; His Tag Mouse IL-23A&IL-12B Heterodimer Protein; His Tag
TNF:TNFR2:TNFR1
H_TNFR2 Null Reporter Cell Line H_TNFR2 Reporter Jurkat Cell Line H_TNFR2 Reporter V2 Cell Line
Cynomolgus_TNFRSF1B(TNFR2) CHO-K1 Cell Line H_TNFRSF1B(TNFR2) CHO-K1 Cell Line H_TNFRSF1B(TNFR2) HEK-293 Cell Line
Membrane Bound H_TNFα CHO-K1 Cell Line Membrane Bound H_TNFα(cleavage-resistant) CHO-K1 Cell Line
Anti-H_TNFRSF1B(TNFR2) hIgG1 Antibody(UC2.3.8) Anti-TNFR1 hIgG1 Antibody(Atrosab) Anti-TNF-α hIgG1 Reference Antibody (Adabio)
Cynomolgus TNFR2 Protein; His Tag Human TNF alpha Protein; hFc Tag Human TNF alpha Protein; His Tag
Human TNFR1 Protein; hFc Tag Human TNFR1 Protein; His Tag Human TNFR2 Protein; hFc Tag
Human TNFR2 Protein; His Tag    
TL1A:DR3(TNFRSF25)
H_TNFRSF25(DR3) Reporter Jurkat Cell Line H_TNFSF15(TL1A) Reporter Cell Line Mouse_TNFRSF25(DR3) Reporter Jurkat Cell Line
Cynomolgus_TNFSF15(TL1A) HEK-293 Cell Line H_TNFRSF25(DR3) HEK-293 Cell Line H_TNFSF15(TL1A) CHO-K1 Cell Line
H_TNFSF15(TL1A) HEK-293 Cell Line Mouse_TNFSF15(TL1A) HEK-293 Cell Line
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(PF-06480605) Anti-H_TNFSF15(TL1A) hIgG1 Antibody(Tulisokibart、PRA-023) Anti-H_TNFSF15(TL1A) hIgG4 Antibody
Anti-TL1A hIgG1 Reference Antibody (Duvbio) Anti-TL1A hIgG1 Reference Antibody (Tulbio) Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35)
Biotinylated Cynomolgus TL1A Protein; His-Avi Tag Biotinylated Human TL1A Protein; His-Avi Tag Cynomolgus TL1A Protein; His Tag
Human TL1A Protein; His Tag    
ITGA4 ITGB7
Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)    
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.
H_TNFRSF25(DR3) CHO-K1 Cell Line
Cat. No.
GM-C28600
Size
1 vial
Quote
Specifications
Data Display
Materials
Cell Culture
Sequence
Related products
Specifications
Cat. No GM-C28600
Product H_TNFRSF25(DR3) CHO-K1 Cell Line
Description H_TNFRSF25(DR3) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human TNFRSF25(DR3).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TNFRSF25(DR3)
Gene ID/Uniprot ID Q93038-1(AA Met 1 - Gln 199)
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Cat. No GM-C28600
Product H_TNFRSF25(DR3) CHO-K1 Cell Line
Description H_TNFRSF25(DR3) CHO-K1 Cell Line is a clonal stable CHO-K1 cell line constitutively expressing human TNFRSF25(DR3).
Product Format 1 vial of frozen cells
Quantity 5E6 Cells per vial,1 mL
Storage Conditions Liquid nitrogen immediately upon receipt
Target Human_TNFRSF25(DR3)
Gene ID/Uniprot ID Q93038-1(AA Met 1 - Gln 199)
Host Cell CHO-K1
Recovery Medium F12K+10% FBS+1% P.S
Growth medium F12K+10% FBS+1% P.S+4 μg/mL Puromycin
Note None
Freezing Medium 90% FBS+10% DMSO
Growth properties Adherent
Growth Conditions 37°C, 5% CO₂
Safety considerations Biosafety Level 2
Mycoplasma Testing The cell line has been screened to confirm the absence of Mycoplasma species.
Data Display
Expression
H_TNFRSF25(DR3) CHO-K1 Cell Line (Cat. GM-C28600) was determined by flow cytometry using Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) (Cat. GM-58913AB).
Stability
The passage stability of the H_TNFRSF25(DR3) CHO-K1 Cell Line (Cat. GM-C28600) was determined by flow cytometry using Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) (Cat. GM-58913AB).
Materials
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) Genomeditech/GM-58913AB
Reagent Ordering Information
F12K BOSTER/PYG0036
Fetal Bovine Serum ExCell/FSP500
Pen/Strep Thermo/15140-122
Puromycin Genomeditech/GM-040401
Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35) Genomeditech/GM-58913AB
Cell Culture

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Cell Recovery

Recovery Medium: F12K+10% FBS+1% P.S

To insure the highest level of viability, thaw the vial and initiate the culture as soon as possible upon receipt. If upon arrival, continued storage of the frozen culture is necessary, it should be stored in liquid nitrogen vapor phase and not at -70°C. Storage at -70°C will result in loss of viability.

a)       Thaw the vial by gentle agitation in a 37°C water bath. To reduce the possibility of contamination, keep the O-ring and cap out of the water. Thawing should be rapid (approximately 2 - 3 minutes).

b)       Remove the vial from the water bath as soon as the contents are thawed, and decontaminate by dipping in or spraying with 70% ethanol. All of the operations from this point on should be carried out under strict aseptic conditions.

c)       Transfer the vial contents to a centrifuge tube containing 5.0 mL complete culture medium and spin at approximately 176 x g for 5 minutes. Discard supernatant.

d)       Resuspend cell pellet with the recommended recovery medium. And dispense into appropriate culture dishes.

e)       Incubate the culture at 37°C in a suitable incubator. A 5% CO₂ in air atmosphere is recommended if using the medium described on this product sheet.

Cell Freezing

Freezing Medium: 90% FBS+10% DMSO

a)          Centrifuge at 176 x g for 3 minutes to collect cells.

b)         Resuspend the cells in pre-cooled freezing medium and adjust the cell density to 5E6 cells/mL.

c)          Aliquot 1 mL into each vial.

d)         Place the vial in a controlled-rate freezing container and store at -80°C for at least 1 day, then transfer to liquid nitrogen as soon as possible.

Cell passage

Growth medium: F12K+10% FBS+1% P.S+4 μg/mL Puromycin

For the first 1 to 2 passages post-resuscitation, use the recovery medium. Once the cells have stabilized, switch to a growth medium.

a)          Remove and discard culture medium.

b)         Briefly rinse the cell layer with PBS to remove all traces of serum that contains trypsin inhibitor.

c)          Add 1.0 mL of 0.25% (w/v) Trypsin-EDTA solution to dish and observe cells under an inverted microscope until cell layer is dispersed (usually within 2 to 3 minutes at 37°C).

d)         Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37°C to facilitate dispersal.

e)          Add 2.0 mL of growth medium to mix well and aspirate cells by gently pipetting.

f)          After centrifugation, resuspend the pellet and add appropriate aliquots of the cell suspension to new culture vessels.

g)         Incubate cultures at 37°C.

Subcultivation Ratio: A subcultivation ratio of 1:4 - 1:5 is recommended

Medium Renewal: Every 2 to 3 days

Notes

a)          After the stabilization of the cell condition, there will be fewer dead cells post-passage, the cell growth rate will tend to stabilize, cell morphology will become uniform, and the cells will appear robust.

Sequence

  TNFRSF25(DR3) Q93038-1(SP-ECD):MEQRPRGCAAVAAALLLVLLGARAQGGTRSPRCDCAGDFHKKIGLFCCRGCPAGHYLKAPCTEPCGNSTCLVCPQDTFLAWENHHNSECARCQACDEQASQVALENCSAVADTRCGCKPGWFVECQVSQCVSSSPFYCQPCLDCGALHRHTRLLCSRRDTDCGTCLPGFYEHGDGCVSCPTSTLGSCPERCAAVCGWRQ

  TNFRSF25(DR3) Q93038-1(SP-ECD):MEQRPRGCAAVAAALLLVLLGARAQGGTRSPRCDCAGDFHKKIGLFCCRGCPAGHYLKAPCTEPCGNSTCLVCPQDTFLAWENHHNSECARCQACDEQASQVALENCSAVADTRCGCKPGWFVECQVSQCVSSSPFYCQPCLDCGALHRHTRLLCSRRDTDCGTCLPGFYEHGDGCVSCPTSTLGSCPERCAAVCGWRQ

Related products
IL-23
H_IL-23 Reporter 293 Cell Line H_IL-23 Reporter 293 DDX35TM Cell Line Cynomolgus_IL-23R HEK-293 Cell Line
H_IL-23R HEK-293 Cell Line H_IL-23R IL12RB1 HEK-293 Cell Line Membrane bound H_IL-23 CHO-K1 Cell Line
Anti-IL23A hIgG1 Reference Antibody (Gusebio) Anti-IL23A hIgG1 Reference Antibody (Risbio) Anti-IL-23R hIgG1 Antibody(5D4)
Biotinylated Human IL-23A&IL-12B Heterodimer Protein; His-Avi Tag Cynomolgus IL-23A & Human IL-12B Heterodimer Protein; His Tag Cynomolgus IL-23A & Mouse IL-12B Heterodimer Protein; His Tag
Cynomolgus IL-23R Protein; hFc Tag Human IL-23A & Mouse IL-12B Heterodimer Protein; His Tag Human IL-23A&IL-12B Heterodimer Protein; His Tag
Human IL-23R Protein; hFc Tag Human IL-23R Protein; His Tag Mouse IL-23A&IL-12B Heterodimer Protein; His Tag
TNF:TNFR2:TNFR1
H_TNFR2 Null Reporter Cell Line H_TNFR2 Reporter Jurkat Cell Line H_TNFR2 Reporter V2 Cell Line
Cynomolgus_TNFRSF1B(TNFR2) CHO-K1 Cell Line H_TNFRSF1B(TNFR2) CHO-K1 Cell Line H_TNFRSF1B(TNFR2) HEK-293 Cell Line
Membrane Bound H_TNFα CHO-K1 Cell Line Membrane Bound H_TNFα(cleavage-resistant) CHO-K1 Cell Line
Anti-H_TNFRSF1B(TNFR2) hIgG1 Antibody(UC2.3.8) Anti-TNFR1 hIgG1 Antibody(Atrosab) Anti-TNF-α hIgG1 Reference Antibody (Adabio)
Cynomolgus TNFR2 Protein; His Tag Human TNF alpha Protein; hFc Tag Human TNF alpha Protein; His Tag
Human TNFR1 Protein; hFc Tag Human TNFR1 Protein; His Tag Human TNFR2 Protein; hFc Tag
Human TNFR2 Protein; His Tag    
TL1A:DR3(TNFRSF25)
H_TNFRSF25(DR3) Reporter Jurkat Cell Line H_TNFSF15(TL1A) Reporter Cell Line Mouse_TNFRSF25(DR3) Reporter Jurkat Cell Line
Cynomolgus_TNFSF15(TL1A) HEK-293 Cell Line H_TNFRSF25(DR3) HEK-293 Cell Line H_TNFSF15(TL1A) CHO-K1 Cell Line
H_TNFSF15(TL1A) HEK-293 Cell Line Mouse_TNFSF15(TL1A) HEK-293 Cell Line
Anti-H_TNFSF15(TL1A) hIgG1 Antibody(PF-06480605) Anti-H_TNFSF15(TL1A) hIgG1 Antibody(Tulisokibart、PRA-023) Anti-H_TNFSF15(TL1A) hIgG4 Antibody
Anti-TL1A hIgG1 Reference Antibody (Duvbio) Anti-TL1A hIgG1 Reference Antibody (Tulbio) Anti-TNFRSF25(DR3) hIgG1 Antibody(PTX-35)
Biotinylated Cynomolgus TL1A Protein; His-Avi Tag Biotinylated Human TL1A Protein; His-Avi Tag Cynomolgus TL1A Protein; His Tag
Human TL1A Protein; His Tag    
ITGA4 ITGB7
Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)    
Message consultation
reset
submit
Message
Message consultation
reset
submit